Who are Caldera Therapeutics, Inc.'s investors?

Caldera Therapeutics, Inc.'s investors include Atlas Venture, Bain Capital Life Sciences, Janus Henderson Investors, LAV, Omega Funds, venBio Global Strategic, venBio Partners, Vivo Capital.

How much funding has Caldera Therapeutics, Inc. raised?

Caldera Therapeutics, Inc. has disclosed $37.5M raised across 1 round.

Where is Caldera Therapeutics, Inc. headquartered?

Caldera Therapeutics, Inc. is headquartered in Cambridge, US.

Caldera Therapeutics, Inc.

Cambridge, US · Founded 2025 · Delaware corporation · 8 known investors

Biotech

Founders & leadership

Praveen TipirneniExecutive

Board

Michelle Doig inBoard directorPartner at Omega Funds

Aaron RoystonBoard director

Michael Gladstone in 𝕏Board directorPartner at Atlas Venture

Xiaodi SuBoard director

Investors · 8

Atlas Venturereported · 2 sourcesCambridge · $500K – $1Mvia Michael Gladstone · board

Bain Capital Life SciencesreportedBoston

Janus Henderson InvestorsreportedNew York

LAVreportedHong Kong · $5M – $15M

Omega FundsreportedBostonvia Michelle Doig · board

venBio Global StrategicreportedSan Francisco

venBio PartnersreportedSan Francisco

Vivo CapitalreportedPalo Alto · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$37.5M disclosed across 1 round · 2026

▶$37.5MraisedJan 2026 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michelle DoigDirector
Aaron RoystonDirector
Michael GladstoneDirector
Xiaodi SuDirector
Praveen TipirneniExecutive Officer, Director

Offering amount: $37.5M
Amount sold: $37.5M
First sale: Jan 2026
Incorporated: Corporation, Delaware, 2025
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Synlogic (SYBX) Merger with Caldera Therapeutics Signals Market Skepticism Amid High Price-to-Salesgurufocus.com · Jul 2026

Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. in a reverse merger transaction. | MarketScreenermarketscreener.com · Jul 2026

Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placementbusinesswire.com · Jul 2026

Caldera Therapeutics raises USD112.5M to advance novel IBD treatments | HealthCare Middle East & Africa - No.1 Health & Pharma Manufacturing Industry Publicationhealthcaremea.com · Jan 2026

Caldera Therapeutics Launches with $112.5M in Total Capitalfinsmes.com · Jan 2026

Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Diseasebusinesswire.com · Jan 2026

Frequently asked questions

Who are Caldera Therapeutics, Inc.'s investors?: Caldera Therapeutics, Inc.'s investors include Atlas Venture, Bain Capital Life Sciences, Janus Henderson Investors, LAV, Omega Funds, venBio Global Strategic, venBio Partners, Vivo Capital.
How much funding has Caldera Therapeutics, Inc. raised?: Caldera Therapeutics, Inc. has disclosed $37.5M raised across 1 round.
Where is Caldera Therapeutics, Inc. headquartered?: Caldera Therapeutics, Inc. is headquartered in Cambridge, US.